Peter Marks is an American hematologist and oncologist who served as the director of the Center for Biologics Evaluation and Research within the Food and Drug Administration. From Wikipedia
Dr. Prasad's leadership signals a shift toward stricter clinical trial standards, prompting market reactions and public health debate.
